Search

Your search keyword '"Carteni, G."' showing total 187 results

Search Constraints

Start Over You searched for: Author "Carteni, G." Remove constraint Author: "Carteni, G."
187 results on '"Carteni, G."'

Search Results

51. Randomized Phase Ii Trial Avareg (Ml25739) with Bevacizumab (Bev) or Fotemustine (Ftm) in Recurrent Gbm: Final Results from the Randomized Phase Ii Trial

52. LBA11_PR - genitourinary tumours, non prostate Phase III trial of sunitinib (SU) vs placebo (PBO) as adjuvant treatment for high-risk renal cell carcinoma (RCC) after nephrectomy (S-TRAC)

53. 1225P - Preliminary efficacy and safety data of nivolumab in never smoker patients with advanced squamous NSCLC: Experience from Italian sites participating in the Expanded Access Programme (EAP)

55. D27 - Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the phase 3b CONSIGN trial who had progression-free survival (PFS) >4 months (m)

57. C22 - Effectiveness of Axitinib second-line therapy for metastatic renal cell carcinoma: preliminary results from real-word “SAX” observational study

59. High CXCR4 Expression Correlates with Sunitinib Poor Response in Metastatic Renal Cancer

61. Therapeutic management of metastatic breast cancer across Europe: European observatory and survey (EOS).

63. Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer

65. 54 EPIDEMIOLOGY OF THE NEUROENDOCRINE TUMORS DIAGNOSED IN THE CARDARELLI HOSPITAL: A RETRO-SPECTIVE SINGLE-INSTITUTION ANALYSIS OF 299 CASES

72. 6571 POSTER Open-label study of pemetrexed (P) alone or in combination with a platinum in patients (pts) with peritoneal mesothelioma (PM): results from the international expanded access program (EAP)

74. The Grid Resource Broker portal

77. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck

85. High CXCR4 Expression Correlates with Sunitinib Poor Response in Metastatic Renal Cancer

88. Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer

89. The Grid Resource Broker portal

90. Adjuvant Systemic Therapies in Patients with Colorectal Cancer: An Audit on Clinical Practice in Italy

99. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

100. Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study

Catalog

Books, media, physical & digital resources